Literature DB >> 1699122

Human immunoglobulin VH and VK repertoire revealed by in situ hybridization.

V Guigou1, A M Cuisinier, C Tonnelle, D Moinier, M Fougereau, F Fumoux.   

Abstract

We report in this paper the first analysis of the expression pattern of Ig VH and VK families in human adult normal peripheral B lymphocytes, by in situ hybridization using specific VH1 to VH6 and VK1 to VK4 probes, which cover the known human V gene families reported to date. The major families were VH3 and VK1, with the respective gradient VH3 greater than VH4 greater than VH1 greater than VH5 greater than VH6 greater than VH2, and VK1 greater than VK3 greater than VK4 greater than VK2. Using a large sampling of EBV clones, we found that the pattern of VH and VK family usage was similar. The expression level correlated fairly with the estimated gene number for the VH, but diverged noticeably for the K chains. Taken together with the fact that the level of light chain expression (K + lambda) was about two-fold that of heavy chains, these results suggest that the VH and the VK repertoires are not regulated by a similar selective process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699122     DOI: 10.1016/0161-5890(90)90161-r

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation.

Authors:  K E Elagib; M Børretzen; R Jonsson; H J Haga; J Thoen; K M Thompson; J B Natvig
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.

Authors:  J M Bye; C Carter; Y Cui; B D Gorick; S Songsivilai; G Winter; N C Hughes-Jones; J D Marks
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

3.  Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors:  M Viau; M Zouali
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

4.  Analysis of human VH gene repertoire expression in peripheral CD19+ B cells.

Authors:  C Demaison; D David; F Letourneur; J Thèze; S Saragosti; M Zouali
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.

Authors:  H P Brezinschek; S J Foster; R I Brezinschek; T Dörner; R Domiati-Saad; P E Lipsky
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

6.  Biased immunoglobulin light chain use in the Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.

Authors:  Daxing Zhu; Chen Lossos; Jennifer R Chapman-Fredricks; Izidore S Lossos
Journal:  Am J Hematol       Date:  2013-03-28       Impact factor: 10.047

7.  Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction.

Authors:  R Küppers; M Zhao; K Rajewsky; M L Hansmann
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

8.  The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection.

Authors:  H J Ditzel; S M Barbas; C F Barbas; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Insights into the regulation of immunoglobulin light chain gene rearrangements via analysis of the kappa light chain locus in lambda myeloma.

Authors:  Vittorio Perfetti; Maurizio C Vignarelli; Giovanni Palladini; Valentina Navazza; Claudia Giachino; Giampaolo Merlini
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

10.  Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue.

Authors:  C M Brown; C Longhurst; G Haynes; C Plater-Zyberk; A Malcolm; R N Maini
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.